Encompass More Asset Management’s Halozyme HALO Stock Holding History

Encompass More Asset Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$299K	Sell	3,816 -72	-2%	-$4.91K	0.04%	220
2026 Q1	$251K	Sell	3,888 -150	-4%	-$10.6K	0.04%	211
2025 Q4	$272K	Buy	4,038 +105	+3%	+$7.06K	0.05%	209
2025 Q3	$288K	Buy	+3,933	New	+$261K	0.06%	184
2025 Q2	–	Sell	-3,677	Closed	-$235K	–	227
2025 Q1	$235K	Buy	+3,677	New	+$214K	0.07%	167

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Encompass More Asset Management's HALO Position: Q2 2026 in Review

Encompass More Asset Management reduced its Halozyme (HALO) stake by 1.9% in Q2 2026, selling an estimated $4.91K and leaving 3,816 shares worth $299K. The position accounts for 0.04% of the portfolio, ranked #220.

Encompass More Asset Management first reported a position in HALO in Q1 2025 and has held it in 5 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Encompass More Asset Management held 3,816 shares of Halozyme worth $299K as of Q2 2026.
Encompass More Asset Management sold 72 Halozyme shares in Q2 2026, an estimated $4.91K.
Halozyme made up 0.04% of Encompass More Asset Management's portfolio in Q2 2026, its #220 holding.
Encompass More Asset Management first reported a position in Halozyme in Q1 2025 and has held it in 5 quarters since.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Encompass More Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.